Keywords
TelmisartanMedicineRamiprilInternal medicineCardiologyBlood pressure
Affiliated Institutions
Related Publications
Natural History of Asymptomatic Mitral Valve Prolapse in the Community
Background— The outcome of mitral valve prolapse (MVP) is controversial, with marked discrepancies in reported complication rates. Methods and Results— We conducted a community ...
Single Versus Combined Blood Pressure Components and Risk for Cardiovascular Disease
Background— The utility of single versus combined blood pressure (BP) components in predicting cardiovascular disease (CVD) events is not established. We compared systolic BP (S...
Functional hemodynamic monitoring.
Hemodynamic monitoring is a central component of intensive care. Patterns of hemodynamic variables often suggest cardiogenic, hypovolemic, obstructive, or distributive (septic) ...
Heart Disease and Stroke Statistics—2022 Update: A Report From the American Heart Association
Background: The American Heart Association, in conjunction with the National Institutes of Health, annually reports the most up-to-date statistics related to heart disease, stro...
Publication Info
- Year
- 2008
- Type
- article
- Volume
- 66
- Issue
- 6
- Pages
- 705-6; discussion 707
- Citations
- 581
- Access
- Closed
External Links
Citation Metrics
581
OpenAlex
Cite This
Marcin Dominiak
(2008).
[Commentary to the article: ONTARGET Investigators, Yusuf S, Teo KK, Pogue J et al. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med 2008; 358: 1547-59]..
PubMed
, 66
(6)
, 705-6; discussion 707.